Bright Minds Biosciences Inc (DRUG)
Financing Cash Flow
$277.00M
TTM · Period ending: · CAD
DRUG Financing Cash Flow
Latest reported$277.00M CADperiod ending
Latest reported$277.00M CADperiod ending
DRUG TTM Cash from Financing · CAD ($1.01M → $277.00M)
TTM financing cash flow
High-resolution chart · PNG
DRUG financing cash flow history
Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (CAD) |
|---|---|
| 276,995,782 | |
| 279,187,743 | |
| 46,917,427 | |
| 85,567,491 | |
| 52,225,861 | |
| 52,220,774 | |
| 51,973,434 | |
| 810,572 | |
| 812,484 | |
| 812,952 | |
| 813,419 | |
| 2,189,686 | |
| 7,275,587 | |
| 7,309,076 | |
| 7,332,250 | |
| 5,196,190 | |
| 122,234 | |
| -435,319 | |
| 24,277,306 | |
| 26,055,600 | |
| 26,991,950 | |
| 27,527,503 | |
| 2,904,874 | |
| 1,008,390 |